SOX2 and central nervous system cancer: Similarly, SOX2 expression levels were increased in higher grade gliomas compared with Grade I samples, consistent with the expression trend of MRPs (Fig. 3c, d), and the expression level was higher in the glioma cell lines when compared with NHA (Fig. 3e).